Printer Friendly
The Free Library
19,122,084 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

The Larry King Cardiac Foundation Recipient of Medtronic Pacemakers, ICDs and Heart Valves; Donation Provides Cardiac Devices for Life-Saving Procedures for Those in Need.


WASHINGTON -- The Larry King Cardiac Foundation (LKCF LKCF Larry King Cardiac Foundation ) today announced it has received a donation of Medtronic (NYSE NYSE

See: New York Stock Exchange
:MDT MDT
abbr.
Mountain Daylight Time


MDT (in the US and Canada) Mountain Daylight Time

MDT n abbr (US) (= mountain daylight time) →
) pacemakers, implantable cardioverter-defibrillators (ICDs) and heart valves Heart valves
Valves that regulate blood flow into and out of the heart chambers.

Mentioned in: Heart Failure
 for its treatment of patients who cannot afford to pay.

The LKCF will administer the product donations to medical centers in Atlanta, Cleveland, Los Angeles, New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
, and Washington, D.C. that participate in the LKCF affiliate care program. Medtronic will deliver the devices and provide technical support as appropriate.

Pacemakers are small implantable devices that are prescribed for people whose hearts beat too slowly or irregularly. Much like a pacemaker in size, ICDs administer electrical therapy to stop a dangerously fast heart rhythm that often leads to sudden cardiac death Sudden Cardiac Death Definition

Sudden cardiac death (SCD) is an unexpected death due to heart problems, which occurs within one hour from the start of any cardiac-related symptoms. SCD is sometimes called cardiac arrest.
 if not treated. Artificial heart valves - either mechanical or made of human or animal tissue - are implanted to replace a diseased or damaged natural heart valve.

"We applaud The Larry King Cardiac Foundation for its work in providing therapies to those of limited means, and we're proud to be involved in reaching the Foundation's goal of saving a heart each day," said Bill Hawkins, Medtronic president and chief operating officer Chief Operating Officer (COO)

The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president.
. "Medtronic's mission - to alleviate pain, restore health and extend life - is a natural complement to The Larry King Cardiac Foundation's efforts."

"Medtronic's generous donation of its newest cardiac devices greatly enhances the Foundation's efforts to provide life-saving cardiac care for those who cannot afford it. These devices may not only help us save lives, but may enhance living and give those who felt they had no options - a second chance," said Larry King, founder of The Larry King Cardiac Foundation, and internationally renowned host of CNN's "Larry King Live Larry King Live is a nightly CNN interview program hosted by broadcaster and writer Larry King. The show premiered in 1985, and is CNN's most watched program, with over one million viewers nightly. ."

About The Larry King Cardiac Foundation

The Larry King Cardiac Foundation (LKCF) was established in 1988 to provide funding for life-saving treatment for individuals who, due to limited means or inadequate insurance, would otherwise be unable to receive the treatment and care they so desperately need. The Foundation works in conjunction with hospitals throughout the nation to ensure that such patients receive proper medical attention.

About Medtronic

Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world. Last year, the company and its foundation made nearly $50 million in cash and medical device donations to improve the health of people and communities around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's Annual Report on Form 10-K for the year ended April 29, 2005. Actual results may differ materially from anticipated results.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Oct 6, 2005
Words:434
Previous Article:Pediment Exploration Ltd.: TSX Approves Take-Over of Minera Pitalla S.A. de C.V.; Pediment Closes Placement and Moves to a Tier 2 Listing on the TSX...
Next Article:2005 Top 100 Chinese Restaurants in USA To Be Announced Oct. 10; As a $17.5 Billion Annual Sales Industry, Chinese Cuisine Finds Its Way to Daily...
Topics:



Related Articles
Medtronic Supports New European Guidelines Recommending Lifesaving ICDs and CRT as Standard-of-Care Heart Failure Therapies; Recent Clinical Trials...
Medtronic Announces U.S. Introduction of EnTrust(TM) Family of Implantable Defibrillators; Innovative Features Redefine ICDs as Painless, Lifesaving...
Medtronic Introduces Industry's First Catheter-Delivered Pacing Lead to Help Facilitate Selective Site Placement in the Right Heart Chambers.
New Study Results Show Cardiac Resynchronization Therapy Saves Many Lives, Improves Heart Pumping Function and is Cost-Effective.
Medtronic CareLink(R) Network Reaches Significant Patient Milestones; First Internet-Based System to Better Manage Chronic Cardiovascular Disease...
The Larry King Cardiac Foundation Fundraising Gala Underwritten by St. Jude Medical, Inc.; Support Allows for Complete Patient Care to Save a Heart a...
Medtronic Announces Commercial Launch of Concerto and Virtuoso Line of Implantable Cardiac Devices in Europe.
Medtronic Announces First U.S. Implant of Its Melody Transcatheter Valve for Patients with Congenital Heart Disease.
Judge rejects preemption in heart device case.
Mealey Publications (King of Prussia, PA), a unit of LexisNexis, has begun the publication of "Mealey's Litigation Report: Heart Drugs & Devices" to...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles